Nesbeth et al. have recently shown the positive effect of CD4+ T cells in ovarian cancer via the use of a novel mechanism that recruits dendritic cells to the tumor site that in turn activate tumor-specific CD8+ cells which then mediate long-term protection [56]. Here, CD4 is linked to neoplasm.